BELBIN, OLIVIA (IR)
OBelbin@santpau.cat
Cervantes Gonzalez, Alba IR
Lidon Gil, Laia IR
Perlaza Meneses, Danna A. IR
(JIF 2022)
-Colom M, Davies C, Sirisi S, Lee J-E, Simzer EM, Tzioras M, Querol M, Sánchez É, Chang YY, Holt K, McGeachan RI, Rose J, Tulloch J, Wilkins L, Smith C, Andrian T, Belbin O, Pujals S, Horrocks MH, Lleó A, Spires TL. Synaptic oligomeric tau in Alzheimer’s disease A potential culprit in the spread of tau pathology through the brain. NEURON. 2023; 111(14):2170-2183.e6. DOI:10.1016/j.neuron.2023.04.020. PMID:37192625. IF:16,200 (Q1/1D). Document type: Article.
-Ferrer P, Puertollano D, Querol M, Sánchez É, Valle N, Cervantes A, Nuñez R, Pegueroles J, Dols O, Iulita MF, Aldecoa I, Molina L, Sánchez R, Fortea J, Belbin O, Sirisi S, Lleó A. Amyloid precursor protein ßCTF accumulates in synapses in sporadic and genetic forms of Alzheimer’s disease. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023; 49(1):e12879. DOI:10.1111/nan.12879. PMID:36702749. IF:5,000 (Q1/2D). Document type: Article.
-Goossens J, González AC, Dewit N, Lidón L, Fortea J, Alcolea D, Lleó A, Belbin O, Vanmechelen E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimers Research & Therapy. 2023; 15(1):186. DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:9,000 (Q1/1D). Document type: Article.
-Iulita MF, Bejanin A, Vilaplana E, Carmona M, Benejam B, Videla L, Barroeta I, Fernández S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, González S, Torres S, El Bennadi SE, Padilla C, Aranha MR, Estelles T, Illán I, Belbin O, Valle N, Camacho V, Blessing E, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, Blennow K, Alcolea D, Clarimón J, Zaman SH, Blesa R, Lleó A, Fortea J. Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome. Brain Communications. 2023; 5(2):fcad074. DOI:10.1093/braincomms/fcad074. PMID:37056479. Document type: Article.
(JIF 2022)